Tonix Pharmaceuticals
TNXP
TNXP
hedge funds and large institutions have $17.4M invested in Tonix Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$55K
Puts
$150K
Net Calls
-$95K
Net Calls Change
-$174K
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
KCM
1
Kingdon Capital Management
New York
|
$4.17M |
| 2 |
DM
2
Deerfield Management
New York
|
$0 |
| 3 |
BC
3
Broadfin Capital
New York
|
$863K |
| 4 |
4
Millennium Management
New York
|
$1.22M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$1.41M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ARTA
51
A.R.T. Advisors
New York
| – | -$117K | – | – |
|
|
IAM
52
Integre Asset Management
New York
| – | -$139K | – | – |
|
53
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$11K | – | – |
|
|
DM
54
Deerfield Management
New York
| – | -$3.17M | – | – |
|